Literature DB >> 2466402

Endothelial cell activation induced by tumor necrosis factor and lymphotoxin.

D E Cavender1, D Edelbaum, M Ziff.   

Abstract

Alterations in the morphology and histochemistry of vascular endothelial cells (EC) have been repeatedly observed at sites of chronic inflammation and immune reactions. These changes, which are most prominent in the EC postcapillary venules present in areas with large lymphocytic infiltrates, include the acquisition of a columnar or cuboidal morphology, the development of ribonuclease-sensitive metachromasia, and an increase in intracellular organelles. Thus, EC at sites of inflammation appear to be activated and to demonstrate increased metabolic activity. This study reports that both tumor necrosis factor-alpha (TNF) and lymphotoxin (LT) can activate cultured human umbilical vein EC, as measured by: 1) increased adhesiveness for lymphocytes, 2) increased cell metabolism, as measured by RNA and protein synthesis, and 3) increased cell volume. Although gamma interferon (IFN-gamma) and interleukin-1 (IL-1) have been shown previously to stimulate EC adhesiveness for lymphocytes, these two cytokines had only marginal effects on EC RNA and protein synthesis, and both caused a decrease in EC volume. These findings suggest that TNF and LT play a role in the type of activation of EC in vivo that leads to the development of tall endothelium and increased lymphocyte emigration.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2466402      PMCID: PMC1879518     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  58 in total

1.  Specialized structure and metabolic activities of high endothelial venules in rat lymphatic tissues.

Authors:  N D Anderson; A O Anderson; R G Wyllie
Journal:  Immunology       Date:  1976-09       Impact factor: 7.397

2.  Morphology of delayed-type hypersensitivity reactions in man. II. Ultrastructural alterations affecting the microvasculature and the tissue mast cells.

Authors:  A M Dvorak; M C Mihm; H F Dvorak
Journal:  Lab Invest       Date:  1976-02       Impact factor: 5.662

3.  Human vascular endothelial cells in culture. Lack of response to serum growth factors.

Authors:  C C Haudenschild; D Zahniser; J Folkman; M Klagsbrun
Journal:  Exp Cell Res       Date:  1976-03-01       Impact factor: 3.905

4.  Cell-mediated immunity in vitro: a highly sensitive assay for human lymphotoxin.

Authors:  B T Spofford; R A Daynes; G A Granger
Journal:  J Immunol       Date:  1974-06       Impact factor: 5.422

5.  Electron microscopic studies of lymphoid cells in the rheumatoid synovial membrane.

Authors:  I Kobayashi; M Ziff
Journal:  Arthritis Rheum       Date:  1973 Jul-Aug

6.  The ultrastructure of mouse lymph node venules and the passage of lymphocytes across their walls.

Authors:  E J Wenk; D Orlic; E J Reith; J A Rhodin
Journal:  J Ultrastruct Res       Date:  1974-05

7.  Depletion of macrophages and disappearance of postcapillary high endothelial venules in lymph nodes deprived of afferent lymphatic vessels.

Authors:  H R Hendriks; I L Eestermans; E C Hoefsmit
Journal:  Cell Tissue Res       Date:  1980       Impact factor: 5.249

8.  Human pulmonary endothelial cells in culture. Activities of cells from arteries and cells from veins.

Authors:  A R Johnson
Journal:  J Clin Invest       Date:  1980-04       Impact factor: 14.808

9.  Relationship between lymphocyte emigration and vascular endothelium in chronic inflammation.

Authors:  G Nightingale; J V Hurley
Journal:  Pathology       Date:  1978-01       Impact factor: 5.306

10.  Increased adhesion of polymorphonuclear leukocytes to vascular endothelium by specific interaction of endogenous (interleukin-1) and exogenous (lipopolysaccharide) substances with endothelial cells 'in vitro'.

Authors:  C J Dunn; W E Fleming
Journal:  Eur J Rheumatol Inflamm       Date:  1984
View more
  24 in total

1.  A dynamic in vitro BBB model for the study of immune cell trafficking into the central nervous system.

Authors:  Luca Cucullo; Nicola Marchi; Mohammed Hossain; Damir Janigro
Journal:  J Cereb Blood Flow Metab       Date:  2010-09-15       Impact factor: 6.200

2.  Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions.

Authors:  K Selmaj; C S Raine; B Cannella; C F Brosnan
Journal:  J Clin Invest       Date:  1991-03       Impact factor: 14.808

Review 3.  Lymphotoxins: from cytotoxicity to lymphoid organogenesis.

Authors:  H von Boehmer
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-19       Impact factor: 11.205

4.  Degranulation of human mast cells induces an endothelial antigen central to leukocyte adhesion.

Authors:  L M Klein; R M Lavker; W L Matis; G F Murphy
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

5.  The role of tumor necrosis factor-alpha in Henoch-Schonlein purpura.

Authors:  Tae-Sun Ha
Journal:  Pediatr Nephrol       Date:  2004-12-31       Impact factor: 3.714

6.  Correlation of leukocyte interleukin-1 production with the stimulation of prostaglandin and tissue factor synthesis by human umbilical vein endothelial cells.

Authors:  R G Schaub; C J Dunn; M R Deibel; A E Berger; D Wunderlich; W E Fleming
Journal:  Agents Actions       Date:  1990-08

Review 7.  A meta-analysis of candidate gene polymorphisms and ischemic stroke in 6 study populations: association of lymphotoxin-alpha in nonhypertensive patients.

Authors:  Xingyu Wang; Suzanne Cheng; Victoria H Brophy; Henry A Erlich; Christine Mannhalter; Klaus Berger; Wolfgang Lalouschek; Warren S Browner; Yu Shi; E Bernd Ringelstein; Christof Kessler; Jan Luedemann; Klaus Lindpaintner; Lisheng Liu; Paul M Ridker; Robert Y L Zee; Nancy R Cook
Journal:  Stroke       Date:  2009-01-08       Impact factor: 7.914

8.  Augmented levels of macrophage and Th1 cell-related cytokine mRNA in submandibular glands of MRL/lpr mice with autoimmune sialoadenitis.

Authors:  W Mustafa; J Zhu; G Deng; A Diab; H Link; L Frithiof; B Klinge
Journal:  Clin Exp Immunol       Date:  1998-06       Impact factor: 4.330

9.  Prevention of autoimmune demyelination in non-human primates by a cAMP-specific phosphodiesterase inhibitor.

Authors:  C P Genain; T Roberts; R L Davis; M H Nguyen; A Uccelli; D Faulds; Y Li; J Hedgpeth; S L Hauser
Journal:  Proc Natl Acad Sci U S A       Date:  1995-04-11       Impact factor: 11.205

Review 10.  The lesional changes and pathogenesis in the kidney in African swine fever.

Authors:  J Hervás; J C Gómez-Villamandos; A Méndez; L Carrasco; M A Sierra
Journal:  Vet Res Commun       Date:  1996       Impact factor: 2.459

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.